Document complet  |  Dérouler chapitre  |  Etendre sommaire  |  Version HTML imprimable
Adherence to Long-Term Therapies - Evidence for Action
(2003; 211 pages) Voir le document au format PDF
Table des matières
Afficher le documentPreface
Afficher le documentAcknowledgements
Afficher le documentScientific writers
Afficher le documentIntroduction
Afficher le documentTake-home messages
Ouvrir ce répertoire et afficher son contenuSection I - Setting the scene
Ouvrir ce répertoire et afficher son contenuSection II - Improving adherence rates: guidance for countries
Ouvrir ce répertoire et afficher son contenuSection III - Disease-Specific Reviews
Ouvrir ce répertoire et afficher son contenuAnnexes
Ouvrir ce répertoire et afficher son contenuWhere to find a copy of this book

Adherence to Long-Term Therapies - Evidence for Action

World Health Organization 2003

WHO Library Cataloguing-in-Publication Data

Adherence to long-term therapies: evidence for action.
1. Patient compliance. 2. Long-term care. 3. Drug therapy - utilization. 4. Chronic disease - therapy. 5. Health behavior. 6. Evidence-based medicine. I. WHO Adherence to Long Term Therapies Project. II. Global Adherence Interdisciplinary Network.

ISBN 92 4 154599 2

(NLM classification: W 85)

© World Health Organization 2003

All rights reserved.
Publications of the World Health Organization can be obtained from Marketing and Dissemination, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel: +41 22 791 2476; fax: +41 22 791 4857; email: Requests for permission to reproduce or translate WHO publications - whether for sale or for noncommercial distribution - should be addressed to Publications, at the above address (fax: +41 22 791 4806; email:

The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.

The mention of specific companies or of certain manufacturers' products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters.

The World Health Organization does not warrant that the information contained in this publication is complete and correct and shall not be liable for any damages incurred as a result of its use.

Printed in Switzerland.

All correspondence should be sent to the author. Eduardo Sabaté, World Health Organization, avenue Appia 20, CH-1211 Geneva 27, Switzerland ( Requests for free electronic copies (pdf format only) should be sent to:


vers la section suivante
Le Portail d'information - Médicaments essentiels et produits de santé a été conçu et est maintenu par l'ONG Human Info. Dernière mise à jour: le 6 décembre 2017